1 and Claps et al2 for their interest in our work and for highlighting issues relevant to the interpretation of this first-in-field phase II study evaluating intravesical recombinant BCG (rBCG) added to neoadjuvant chemo-immunotherapy in muscle-invasive bladder cancer (MIBC).3 We thank Miao and Wuand Claps et alfor their interest in our work and for highlighting issues relevant to the interpretation of this first-in-field phase II study evaluating intravesical recombinant BCG (rBCG) added to...
Richard Cathomas
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Richard
Contact Richard, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack